LENZ Therapeutics, Inc.
LENZ
$38.63
-$1.06-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.84% | -9.05% | 217.70% | 146.28% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.56% | 14.87% | 91.24% | 101.80% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Current Assets | 7.15% | -8.68% | 215.15% | 145.56% | -- |
|
|
|||||
| Total Current Assets | 7.15% | -8.68% | 215.15% | 145.56% | -- |
| Net Property, Plant & Equipment | 12.53% | 218.18% | 434.68% | 365.77% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.59% | 6,557.14% | -49.35% | -25.91% | -- |
| Total Assets | 7.25% | -7.39% | 205.93% | 143.02% | -- |
|
|
|||||
| Total Accounts Payable | -35.22% | -48.66% | -25.46% | -46.35% | -- |
| Total Accrued Expenses | 100.17% | -61.15% | -55.93% | -62.47% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.73% | 17.55% | 313.87% | 369.92% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.15% | -54.63% | -43.79% | -54.23% | -- |
|
|
|||||
| Total Current Liabilities | 21.15% | -54.63% | -43.79% | -54.23% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -45.91% | 331.41% | 323.96% | 319.82% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -54.29% | -- |
| Total Liabilities | 12.85% | -51.75% | -40.40% | -49.30% | -- |
|
|
|||||
| Common Stock & APIC | 20.86% | 13.37% | 4,040.29% | 4,299.48% | -- |
| Retained Earnings | -42.90% | -42.67% | -52.25% | -84.98% | -- |
| Treasury Stock & Other | 161.29% | 12,400.00% | 3,166.67% | 10,560.00% | -- |
| Total Common Equity | 6.97% | -3.11% | 335.09% | 438.13% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.97% | -3.11% | 335.09% | 438.13% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.97% | -3.11% | 295.90% | 187.19% | -- |
|
|
|||||